Sulforaphane vs Curcumin — the Nrf2 inducer and the NF-κB inhibitor
Two of the most-trialled plant-derived anti-inflammatories with very different primary mechanisms. Curcumin (from turmeric) is principally an NF-κB pathway modulator with strong RCT evidence in osteoarthritis pain. Sulforaphane (from broccoli sprouts) is the canonical Nrf2 pathway inducer, activating the body's endogenous antioxidant and phase II detoxification machinery, with the most substantive human evidence in autism spectrum (Singh 2014 follow-on trials) and biomarker-level air pollution detoxification studies. They aren't really competitors — they hit different molecular targets and the right pick depends on which target you want engaged.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Knee osteoarthritis pain | Curcumin | Multiple meta-analyses, including a 2025 NMA, rank bioavailable curcumin among top-effect supplements for OA pain. |
| Endogenous antioxidant capacity (glutathione, Nrf2 targets) | Sulforaphane | Sulforaphane is the most potent natural Nrf2 inducer; upregulates GST, NQO1, and downstream antioxidant enzymes. |
| Autism behavioural symptoms (research setting) | Sulforaphane | Singh 2014 RCT (n=44) showed meaningful improvements; subsequent replications are mixed. |
| Glucose / metabolic markers | Both have signal; sulforaphane has Axelsson 2017 | Sulforaphane reduced HbA1c in T2D obese patients in Axelsson 2017; curcumin has metabolic-marker meta-analyses too. |
| Inflammatory biomarkers (CRP, IL-6) | Curcumin (more trial volume) | Larger trial volume; modest reductions in inflammatory markers across many small RCTs. |
| Cancer prevention / chemoprotection | Neither at supplement dose | Mechanistically interesting, but human chemoprevention trials are not yet supportive at supplement-relevant exposures. |
How they compare on biology
What curcumin does
Curcumin is a polyphenol from turmeric (Curcuma longa) that inhibits multiple pro-inflammatory signalling pathways: NF-κB, COX-2 (modestly), 5-LOX, and several cytokines (TNF-α, IL-1β, IL-6). It also has antioxidant activity but works upstream by reducing the production of inflammatory mediators rather than scavenging downstream. The primary clinical application — knee osteoarthritis pain — fits this mechanism: chronic inflammatory contribution to joint pain, modulated by reducing inflammatory signalling.
What sulforaphane does
Sulforaphane is an isothiocyanate produced when myrosinase enzymes hydrolyse glucoraphanin in damaged broccoli (and especially broccoli sprouts, which contain 10–100× more glucoraphanin than mature broccoli). It is the most potent natural inducer of Nrf2, a transcription factor that regulates ~200 cytoprotective genes including glutathione synthesis, NAD(P)H quinone oxidoreductase 1 (NQO1), glutathione S-transferases (GSTs), and superoxide dismutase. The mechanism is "turn on the body's own defences" rather than direct antioxidant scavenging.
Bioavailability matters for both
Native curcumin has terrible oral bioavailability (~1% as parent compound). Modern formulations — phytosome (Meriva), liposomal, NovaSOL, Theracurmin, BCM-95, and piperine combinations — improve absorption 7–30×. Generic turmeric capsules are not appropriate substitutes for the trial-grade preparations. Sulforaphane bioavailability depends critically on myrosinase: capsules of dehydrated broccoli sprout powder vary widely in active sulforaphane content. Branded glucoraphanin-plus-myrosinase preparations (Avmacol, BroccoMax) approximate fresh-sprout exposure; many cheaper "sulforaphane" supplements deliver little active compound.
Trial evidence — curcumin
Knee OA: 2025 network meta-analysis and multiple earlier meta-analyses converge on a clinically meaningful pain reduction with bioavailable curcumin, comparable to NSAID short-term effects with a much better GI safety profile. Inflammatory bowel disease: small positive trials as add-on to mesalamine. Depression: small positive trials, mixed signal. Metabolic syndrome and diabetes: modest improvements in lipid markers and fasting glucose. The trial volume is large; the per-trial quality is mixed.
Trial evidence — sulforaphane
Axelsson 2017 (n=97, T2DM with obesity): broccoli sprout extract reduced fasting glucose and HbA1c modestly. Singh 2014 (n=44, autism spectrum): improvements on standardised behavioural scales over 18 weeks; subsequent replications are mixed. Lozanovski 2020 (pancreatic cancer adjunct): no clinical endpoint benefit. Air pollution detoxification studies (Egner 2014): meaningful biomarker-level acceleration of benzene and acrolein metabolite excretion. Outside these specific populations, sulforaphane trials are small and surrogate-endpoint heavy.
Dosing
Curcumin: 500 mg b.i.d. of a bioavailable formulation (phytosome, liposomal, BCM-95) with a fat-containing meal. Sulforaphane: 10–40 mg sulforaphane equivalent daily; or 100 g fresh broccoli sprouts ~3× weekly. Avmacol-style branded supplements provide measured glucoraphanin + myrosinase to ensure active sulforaphane delivery.
Safety
Curcumin: well tolerated; mild GI effects; mild anticoagulant effect at high doses — caution with warfarin and around surgery; rare hepatotoxicity case reports, mostly with very high-dose or contaminated products. Sulforaphane: well tolerated at trial doses; rare GI upset; theoretical concern about thyroid (broccoli contains goitrogens, but at supplement-relevant doses with adequate iodine, this is not a meaningful clinical issue).
Who should consider supplementing
Curcumin: adults with chronic inflammatory pain, especially knee OA, where NSAIDs are limited by GI or CV side effects. Sulforaphane: adults targeting glutathione capacity or phase II detoxification (occupational exposure, heavy air pollution); families using it as an autism adjunct under medical guidance.
Who should skip
Users on warfarin or scheduled surgery — pause curcumin 2 weeks before. Users on multiple anticoagulants — consult prescriber for both. Users with documented turmeric or curcumin allergy. Users who expect chemoprevention or anti-cancer benefit at supplement-relevant doses — the evidence does not support this expectation.
What the price difference buys you
Quality bioavailable curcumin: $0.50–1/day at trial-grade dosing. Quality sulforaphane (Avmacol, BroccoMax): $0.70–1.20/day. Eating broccoli sprouts 3×/week at home: $0.20–0.50/day with a sprouter and seeds. The home sprout route is the cheapest and most concentrated natural sulforaphane source.
What we'd actually buy
For knee OA pain: bioavailable curcumin (Meriva, BCM-95, or Theracurmin), 500 mg b.i.d. with meals containing fat.
For Nrf2 / phase II detoxification: Avmacol-style branded glucoraphanin+myrosinase 10–30 mg sulforaphane equivalent daily, or home-sprouted broccoli sprouts 3–5× weekly.
For overall systemic inflammation: dietary pattern (Mediterranean, anti-inflammatory diet), regular exercise, adequate sleep, and weight management produce larger effects than either supplement alone.
Sources
- Singh K, et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. 2014;111(43):15550–15555. PMID: 25313065
- Axelsson AS, et al. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med. 2017;9(394):eaah4477. PMID: 28615356
- Daily JW, et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717–729. PMID: 27533649
- Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017;6(10):92. PMID: 29065496
- Egner PA, et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage. Cancer Prev Res. 2014;7(8):813–823. PMID: 24913818
- Houghton CA. Sulforaphane: its "coming of age" as a clinically relevant nutraceutical in the prevention and treatment of chronic disease. Oxid Med Cell Longev. 2019;2019:2716870. PMID: 31737167